DETECTION OF APOPTOSIS-ASSOCIATED DNA FRAGMENTATION USING A RAPID AND QUANTITATIVE FILTER ELUTION ASSAY

被引:37
作者
BERTRAND, R
KOHN, KW
SOLARY, E
POMMIER, Y
机构
[1] Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
[2] Louis-Charles Simard Research Center, Montreal Cancer Institute, Montreal, Quebec, H2L 4
[3] Hematology Department, C.H.U. Le Bocage, Dijon, 21034
关键词
APOPTOSIS; DNA FRAGMENTATION; STAUROSPORINE;
D O I
10.1002/ddr.430340206
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DNA degradation to oligonucleosome size fragments is one of the cellular markers of apoptosis. Based on DNA filter elution methodology, we have designed a simple assay to monitor apoptosis-associated DNA fragmentation from cultured cells or from a reconstituted cell-free system. The cells are prelabeled with [C-14]-thymidine for one cell cycle and chased in nonradioactive medium for a few hours in order to allow incorporation of the radiolabeled thymidine in high molecular weight DNA. After the apoptosis-inducing treatment, cells (or subcellular fractions of the cell-free system) are deposited onto a protein-adsorbant filter and washed with physiological saline. Lysis is then performed with a mild detergent (sarkosyl) and 2 M salt. The lysis fraction is collected, counted, and computed to calculate the fraction of DNA in the lysis fraction. In normal cells more than 90% of the DNA remains on the filter, while in apoptotic cells the kinetics of DNA fragmentation can be monitored and more than 80% of the counts can be found in the lysis. The DNA filter elution assay is sensitive, quantitative, and rapid. By using different types of filters and lysis solution (+/- proteinase), the protein-bonding to the DNA fragments can be determined. Some applications of this assay to study the effects and mechanisms of action of new therapeutic drugs are presented and discussed. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 28 条
  • [1] ACTIVATION OF PROGRAMMED CELL-DEATH (APOPTOSIS) BY CISPLATIN, OTHER ANTICANCER DRUGS, TOXINS AND HYPERTHERMIA
    BARRY, MA
    BEHNKE, CA
    EASTMAN, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) : 2353 - 2362
  • [2] BERTRAND R, 1991, CANCER RES, V51, P6280
  • [3] APOPTOSIS AND ITS MODULATION IN HUMAN PROMYELOCYTIC HL-60 CELLS TREATED WITH DNA TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS
    BERTRAND, R
    SOLARY, E
    JENKINS, J
    POMMIER, Y
    [J]. EXPERIMENTAL CELL RESEARCH, 1993, 207 (02) : 388 - 397
  • [4] BERTRAND R, 1993, EXP CELL RES, V211, P314
  • [5] BROWN DG, 1993, J BIOL CHEM, V268, P3037
  • [6] APOPTOSIS AND DISEASE
    CARSON, DA
    RIBEIRO, JM
    [J]. LANCET, 1993, 341 (8855) : 1251 - 1254
  • [7] DELBINO G, 1991, CANCER RES, V51, P1165
  • [8] ANALYSIS AND DISCRIMINATION OF NECROSIS AND APOPTOSIS (PROGRAMMED CELL-DEATH) BY MULTIPARAMETER FLOW-CYTOMETRY
    DIVE, C
    GREGORY, CD
    PHIPPS, DJ
    EVANS, DL
    MILNER, AE
    WYLLIE, AH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1133 (03) : 275 - 285
  • [9] MULTIPLE PATHWAYS TO APOPTOSIS
    EVANS, VG
    [J]. CELL BIOLOGY INTERNATIONAL, 1993, 17 (05) : 461 - 476
  • [10] AN IMPROVED METHOD FOR THE DETECTION OF DNA FRAGMENTATION
    FACCHINETTI, A
    TESSAROLLO, L
    MAZZOCCHI, M
    KINGSTON, R
    COLLAVO, D
    BIASI, G
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 136 (01) : 125 - 131